Market Research - Eveleigh, New South Wales, AU
BCAL Diagnostics is an Australian-owned, ASX listed, biotechnology company. Since its establishment in 2010, BCAL Diagnostics has been striving to help identify health issues in women that is safe, accessible and cost effective.
DoubleClick
Outlook
Varnish
Facebook Login (Connect)
Google Cloud Hosting
Mobile Friendly
Are you looking for the contact information of BCAL Diagnostics Pty Ltd? You're in the right place! ConnectPlex is the premier platform for connecting with professionals in the industry. Our extensive database contains contact information for millions of companies worldwide, including BCAL Diagnostics Pty Ltd. With our AI-powered lead generation products, you can easily find and connect with the right people in this company and others. Why wait? Sign up for ConnectPlex today and start building meaningful connections with professionals in the industry. Our platform is designed to help you find and connect with the right people, so you can grow your business and achieve success. With ConnectPlex, you'll have access to a wealth of information and resources that will help you stand out from the competition. So why wait? Join ConnectPlex today and start connecting with people working in BCAL Diagnostics Pty Ltd!
BCAL Diagnostics Pty Ltd is a company based in Sydney, Australia that is dedicated to revolutionizing the way breast cancer is diagnosed. With a focus on market research, the company aims to introduce a blood test for the detection of breast cancer, providing a more effective and efficient method for screening and diagnosis. This is particularly important as breast cancer is the most common cancer among women, and early detection is crucial for effective treatment. BCAL Diagnostics' website, bcaldiagnostics.com, provides more information on their mission and research. They also have a presence on LinkedIn, where they share updates and insights into their work. While the company's size and revenue are not publicly available, their commitment to improving breast cancer diagnosis is evident in their dedication to research and development. With a focus on shifting the paradigm in breast cancer diagnosis, BCAL Diagnostics is poised to make a significant impact in the medical industry.
Our goal is to change the way breast cancer is diagnosed by creating a simple blood test that can detect the disease. Breast cancer is the most common cancer in women, so it's important to have a reliable and effective way to screen for it.